Page last updated: 2024-08-23

pravastatin and Placenta Diseases

pravastatin has been researched along with Placenta Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaemsaithong, P; Chaiworapongsa, T; DeCherney, AH; Hassan, SS; Hernandez-Andrade, E; Kim, CJ; Korzeniewski, SJ; McCoy, MC; Romero, R; Segars, JH; Yeo, L	1
Chapman, KE; Holmes, MC; Miller, MR; Moran, CM; Noble, J; Rog-Zielinska, EA; Seckl, JR; Tesic, D; Thomson, A; Wyrwoll, CS	1

Other Studies

2 other study(ies) available for pravastatin and Placenta Diseases

Article	Year
Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:6 Topics: Abortion, Habitual; Adult; Animals; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Placenta Diseases; Pravastatin; Pregnancy; Vascular Endothelial Growth Factor Receptor-1	2016
Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess. Proceedings of the National Academy of Sciences of the United States of America, 2016, May-31, Volume: 113, Issue:22 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Anticholesteremic Agents; Female; Fetal Growth Retardation; Glucocorticoids; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Placenta Diseases; Pravastatin; Pregnancy; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2016

Article

Year

Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:6

Topics: Abortion, Habitual; Adult; Animals; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Placenta Diseases; Pravastatin; Pregnancy; Vascular Endothelial Growth Factor Receptor-1

2016

Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.

Proceedings of the National Academy of Sciences of the United States of America, 2016, May-31, Volume: 113, Issue:22

Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Anticholesteremic Agents; Female; Fetal Growth Retardation; Glucocorticoids; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Placenta Diseases; Pravastatin; Pregnancy; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2016